D. Tolzman

900 total citations
8 papers, 650 citations indexed

About

D. Tolzman is a scholar working on Surgery, Transplantation and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, D. Tolzman has authored 8 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 7 papers in Transplantation and 1 paper in Cardiology and Cardiovascular Medicine. Recurrent topics in D. Tolzman's work include Renal Transplantation Outcomes and Treatments (7 papers), Organ Transplantation Techniques and Outcomes (5 papers) and Transplantation: Methods and Outcomes (4 papers). D. Tolzman is often cited by papers focused on Renal Transplantation Outcomes and Treatments (7 papers), Organ Transplantation Techniques and Outcomes (5 papers) and Transplantation: Methods and Outcomes (4 papers). D. Tolzman collaborates with scholars based in United States and Canada. D. Tolzman's co-authors include William E. Fitzsimmons, Stuart D. Russell, Mark Zucker, Jon Kobashigawa, Gregory A. Ewald, Lee R. Goldberg, Howard J. Eisen, L.W. Miller, R. First and Gabriel M. Danovitch and has published in prestigious journals such as American Journal of Kidney Diseases, Transplantation and American Journal of Transplantation.

In The Last Decade

D. Tolzman

8 papers receiving 628 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Tolzman United States 6 512 398 134 98 72 8 650
Samuel Weinstein United States 13 335 0.7× 223 0.6× 117 0.9× 67 0.7× 18 0.3× 21 570
Peter Schenker Germany 13 352 0.7× 358 0.9× 41 0.3× 170 1.7× 11 0.2× 59 599
David S. Seaman United States 9 297 0.6× 419 1.1× 74 0.6× 123 1.3× 8 0.1× 12 582
L. Mared Sweden 13 256 0.5× 450 1.1× 30 0.2× 56 0.6× 41 0.6× 20 711
M. Cabello Spain 11 223 0.4× 135 0.3× 58 0.4× 83 0.8× 13 0.2× 35 383
Chang‐Kwon Oh South Korea 15 286 0.6× 414 1.0× 57 0.4× 190 1.9× 5 0.1× 57 672
E. Solà Spain 13 277 0.5× 151 0.4× 72 0.5× 112 1.1× 12 0.2× 50 477
Vanji Karthikeyan United States 9 166 0.3× 75 0.2× 44 0.3× 40 0.4× 78 1.1× 14 358
M Moukarzel France 13 120 0.2× 268 0.7× 41 0.3× 179 1.8× 12 0.2× 70 553
Michael Rizzari United States 15 214 0.4× 476 1.2× 28 0.2× 179 1.8× 9 0.1× 52 681

Countries citing papers authored by D. Tolzman

Since Specialization
Citations

This map shows the geographic impact of D. Tolzman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Tolzman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Tolzman more than expected).

Fields of papers citing papers by D. Tolzman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Tolzman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Tolzman. The network helps show where D. Tolzman may publish in the future.

Co-authorship network of co-authors of D. Tolzman

This figure shows the co-authorship network connecting the top 25 collaborators of D. Tolzman. A scholar is included among the top collaborators of D. Tolzman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Tolzman. D. Tolzman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kobashigawa, Jon, L.W. Miller, Stuart D. Russell, et al.. (2006). Tacrolimus with Mycophenolate Mofetil (MMF) or Sirolimus vs. Cyclosporine with MMF in Cardiac Transplant Patients: 1-Year Report. American Journal of Transplantation. 6(6). 1377–1386. 221 indexed citations
4.
Johnson, Christopher P., Nasimul Ahsan, Thomas A. Gonwa, et al.. (2000). RANDOMIZED TRIAL OF TACROLIMUS (PROGRAF) IN COMBINATION WITH AZATHIOPRINE OR MYCHOPHENOLATE MOFETIL VERSUS CYCLOSPORINE (NEORAL) WITH MYCOPHENOLATE MOFETIL AFTER CADAVERIC KIDNEY TRANSPLANTATION1, 2. Transplantation. 69(5). 834–841. 229 indexed citations
5.
Kaufman, Dixon B., G.A. Amos Burke, D. E. R. Sutherland, et al.. (2000). THE ROLE OF ANTIBODY INDUCTION IN SIMULTANEOUS PANCREAS KIDNEY (SPK) TRANSPLANT PATIENTS RECEIVING TACROLIMUS + MYCOPHENOLATE MOFETIL (MMF) IMMUNOSUPPRESSION.. Transplantation. 69(Supplement). S206–S206. 8 indexed citations
6.
Wilson, Richard A., et al.. (1994). Prospective Risk Stratification in Renal Transplant Candidates for Cardiac Death. American Journal of Kidney Diseases. 24(1). 65–71. 63 indexed citations
7.
Batiuk, Thomas D., et al.. (1993). Incidence and type of cancer following the use of OKT3: a single center experience with 557 organ transplants.. PubMed. 25(1 Pt 2). 1391–1391. 8 indexed citations
8.
Wm, Bennett, et al.. (1991). Outcome of renal transplantation at Oregon Health Sciences University: 1982 to 1990.. PubMed. 153–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026